Evidence map›Paper›PMID 23505611›Full record

ArticleJournal of materials chemistry. B2013

A Novel Core-Shell Microcapsule for Encapsulation and 3D Culture of Embryonic Stem Cells.

Wujie Zhang, Shuting Zhao, Wei Rao, Jedidiah Snyder, Jung K Choi, Jifu Wang, Iftheker A Khan, Navid B Saleh, Peter J Mohler, Jianhua Yu and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of materials chemistry. B, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Three-dimensional core-shell alginate microsphere for cancer hypoxia simulationFrontiers in bioengineering and biotechnology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Wujie ZhangDepartment of Biomedical Engineering, The Ohio State University, Columbus, OH 43210, USA ; Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA ; Biomolecular Engineering Program, Department of Physics and Chemistry, Milwaukee School of Engineering, Milwaukee, WI 53202, USA.
Shuting Zhao
Wei Rao
Jedidiah Snyder
Jung K Choi
Jifu Wang
Iftheker A Khan
Navid B Saleh
Peter J Mohler
Jianhua Yu
Thomas J Hund
Chuanbing Tang
Xiaoming He
Lung Institute · USThe Ohio State University · USUniversity of South Carolina · USMilwaukee School of Engineering · US

Funding

Microencapsulation of oocytes for low-CPA (cryoprotectant) vitrificationR01EB012108 · NIBIB · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HE, XIAOMING · 2011 to 2014
$1.3M
NIBIB NIH HHS R01 EB012108
6 · The paper itself

Abstract

In this study, we report the preparation of a novel microcapsule of ~ 100 μm with a liquid (as compared to solid-like alginate hydrogel) core and an alginate-chitosan-alginate (ACA) shell for encapsulation and culture of embryonic stem (ES) cells in the miniaturized 3D space of the liquid core. Murine R1 ES cells cultured in the microcapsules were found to survive (> 90%) well and proliferate to form either a single aggregate of pluripotent cells or embryoid body (EB) of more differentiated cells in each microcapsule within 7 days, dependent on the culture medium used. This novel microcapsule technology allows massive production of the cell aggregates or EBs of uniform size and controllable pluripotency, which is important for the practical application of stem cell based therapy. Moreover, the semipermeable ACA shell was found to significantly reduce immunoglobulin G (IgG) binding to the encapsulated cells by up to 8.2 times, compared to non-encapsulated cardiac fibroblasts, mesenchymal stem cells, and ES cells. This reduction should minimize inflammatory and immune responses induced damage to the cells implanted

Identifiers

PMID23505611
PMCPMC3596163
OpenAlexW2144122320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.